Continuing
Medical Education Information
MOOD DISORDERS IN CHILDREN AND ADOLESCENTS:
AN EVIDENCE-BASED
UPDATE ON DIAGNOSIS AND TREATMENT
Date
and Location: January 20, 2024 Webinar
Target Audience:
Child and adolescent psychiatrists and other clinicians
Program Overview:
This program
will consist of six talks—covering mood disorders from childhood through transitional age—and--from diagnosis
to brain mechanisms to treatment. Therapeutic approaches to be discussed include established (neurotherapeutic), evolving
(ketamine), and potential interventions (psychedelics). There will be plenty of time for interactive questions.
Planners and Faculty:
Melissa A. Brotman, PhD
– Content Developer, Speaker
Dr. Brotman does not have any relevant financial relationships with ineligible companies to disclose.
Daniel Dickstein, MD –
Content Developer, Speaker
Dr.
Dickstein does not have any relevant financial relationships with ineligible companies to disclose.
Robert Meisner, MD – Content Developer, Speaker
Dr. Meisner does not have any relevant
financial relationships with ineligible companies to disclose.
Brian Skehan, MD, PhD - Content Developer, Speaker
Dr. Skehan does not have any relevant financial relationships
with ineligible companies to disclose.
Robyn P. Thom, MD – Content Developer, Speaker
Dr. Thom does not have any relevant financial relationships with ineligible companies
to disclose.
Mai
Uchida, MD – Content Developer, Speaker
Dr. Uchida does not have any relevant financial relationships with ineligible companies to disclose.
Sharon Weinstein, MD –
Planner, Content Developer
Dr.
Weinstein does not have any relevant financial relationships with ineligible companies to disclose.
Educational Objectives
After attending
this live seminar, attendees will be able to:
·
Communicate with patients and their families about the meaning and importance of
evidence-based, data-driven, “safety-first” care.
· Discuss
strategies to modify existing evidence-based psychotherapies for youth with autism spectrum disorder.
· Discuss
the potential mechanism of exposure-based cognitive behavioral therapy for irritability.
· Understand
the various models of care on college campuses and opportunities for collaboration.
· Understand
neuroimaging-based identifiers of children at risk for bipolar disorder while presenting with depression.
Accreditation
Statement
Professional
Risk Management Services (PRMS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing
medical education for physicians.
MA Credit Designation Statement
Professional Risk Management Services
(PRMS) designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians
should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
PRMS does not accept financial
support from ineligible companies for CME activities.
Method of Participation
Physicians must attend the live activity and complete a Post Activity Learning Assessment
Tool and Credit Application form to receive a Credit Certificate.
Estimated Time to Complete
3.5 hours